Expanded high-resolution genetic study of 109 Swedish families with Alzheimer's disease

European Journal of Human Genetics

Volumn 16, Issue 2, 2008, Pages 202-208

  Sillén, Anna ^a   Andrade, Jorge ^b   Lilius, Lena ^a   Forsell, Charlotte ^a   Axelman, Karin ^a   Odeberg, Jacob ^b   Winblad, Bengt ^a   Graff, Caroline ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ALBANOVA UNIVERSITY CENTER   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 10; CHROMOSOME 12; CHROMOSOME 19Q; CHROMOSOME 9; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOMICS; GENOTYPE; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PEDIGREE ANALYSIS; PRIORITY JOURNAL; SWEDEN;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS E; FAMILY; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; LINKAGE (GENETICS); LOD SCORE; MALE; MICROSATELLITE REPEATS; SWEDEN;

EID: 38349170135     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/sj.ejhg.5201946     Document Type: Article

References (51)

1. Selkoe DJ: Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Annu Rey Cell Biol 1994; 10 373-403.
2. Haass C, Selkoe DJ: Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide. Cell 1993; 75 1039-1042.
3. Hardy JA, HiggiTs GA: Alzheimer's disease: the amyloid cascade hypothesis. Science 1992; 256: 184-185.
4. Goate A, Chartier-Harlin M-C, Mullan M et al: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704-706.
5. Rovelet-Lecrux A, Hannequin D, Raux G et al: APP locus duplication causes, autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy, Nat Genet 2006; 38: 24-26.
6. Sherrington R, Rogaev EI, Liang Y et al: Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995; 375:754-760.
7. Rogaev EI, Sherrington R, Rogaeva EA et al: Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature1995; 376 775-778.
8. Levy-Lahad E, Wijsman EM, Nemens E et al: A familial Alzheimer's disease locus on chromosome 1. Science 1995; 269: 970-973.
9. Haass C, Hung AY, Selkoe DJ, Teplow DB: Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor. J Biol Chem 1994; 269: 17741-17748.
10. Citron M, Westaway D, Xia W et al: Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med 1997; 3: 67-72.
11. Citron M, Vigo-Pelfrey C, Teplów DB et al: Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer's disease mutation. Proc Natl Acad Sci USA 1994; 91: 11993-11997.
12. Thinakaran G, Borchelt DR, Lee MK et al: Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 1996; 17: 181-190.
13. Blacker D, Haines JL, Rodes L et al: ApoE-4 and age at onset of Alzheimer's disease: The NIMH genetics initiative. Neurology 1997; 48: 139-147.
14. Curtis D, North BV, Sham PC: A novel method of two-locus linkage analysis applied to a genome scan for late onset Alzheimer's disease. Ann Hum Genet 2001; 65: 473-481.
15. Pericak-Vance MA, Bass MP, Yamaoka LH et al: Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. JAMA 1997; 278: 1237- 1241.
16. Olson JM, Goddard KA, Dudek DM: A second locus for very-late-onset Alzheimer disease: A genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region. Am J Hum Genet 2002; 71: 154-161.
17. Myers A, Wavrant De-Vrieze F, Holmans P et al: Full genome screen for Alzheimer disease: Stage II analysis. Am J Med Genet 2002; 114: 235-244.
18. Blacker D, Bertram L, Saunders AJ et al: Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 2003; 12: 23-32.
19. Pericak-Vance MA, Grubber J, Bailey LR et al: Identification of novel genes in late-onset Alzheimer's disease. Exp Gerontol 2000; 35: 1343-1352.
20. Scott WK, Hauser ER, Schmechel DE et al: Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22. Am J Hum Genet 2003; 73: 1041-1051.
21. Li YJ, Scott WK, Hedges DJ et al: Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 2002; 70: 985-993.
22. Hiltunen M, Mannermaa A, Thompson D et al: Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in. Finland. Neurology 2001; 57: 1663-1668.
23. Gordon D, Haynes C, Finch SJ, Brown AM: Increase in linkage information by stratification of pedigree data into gold-standard and standard diagnoses: Application to the NIMH Alzheimer Disease Genetics Initiative Dataset. Hum Hered 2006; 61: 97-103.
24. Lee JH, Mayeux R, Mayo D et al: Fine mapping of 10q and 18q for familial Alzheimer's disease in Caribbean Hispanics. Mol Psychiatry 2004; 9: 1042-1051.
25. Farrer LA, Bowirrat A, Friedland RP, Waraska K, Korczyn AD, Raldwin CT: Identification of multiple loci for Alzheimer disease ina consanguineous Israeli-Arab community. Hum Mol Genet 2003; 12: 415-422.
26. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE: Systematic meta-analyses of Alzheimer disease genetic association studies: The AlzGene database. Nat Genet 2007; 39: 17-23.
27. Kamboh MI: Molecular genetics of late-onset Alzheimer's disease. Ann Hum Genet 2004; 68: 381-404.
28. Sillán A, Forsell C, Lilius L et al: Genome scan on Swedish Alzheimer's disease families. Mol Psychiatry 2006; 11: 182-186.
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ARDRA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology 1984; 34: 939-944.
30. Tariot PN, Mack JL, Patterson MB et al: The behavior rating scale for dementia of the consortium to establish a registry for Alzheimer's disease. The behavioral pathology committee of the consortium to establish a registry for Alzheimer's disease. Am J Psychiatry 1995; 152: 1349-1357.
31. Mirra SS, Heyman A, McKeel D et al: The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-486.
32. Kong A, Gudbjartsson D, Sainz J et al: A high-resolution recombination map of the human genome. Nat Genet 2002; 31: 241-247.
33. Broman KW, Murray JC, Sheffield VC, White RL, Weber JL: Comprehensive human genetic maps: Individual and sex-specific variation in recombination. Am J Hum Genet 1998; 63: 861-869.
34. Dib C, Faure S, Fizames C et al: A comprehensive genetic map of the human genome based on S264 microsatellites. Nature 1996; 380: 152-154.
35. Ott J: Strategies for characterizing highly polymorphic markers in human gene mapping. Am J Hum Genet 1992, 51: 283-290.
36. Gudbjartsson DF, Jonasson K, Frigge ML, Kong A: Allegro, a new computer program for multipoint linkage analysis. Nat Genet 2000; 25: 12-13.
37. McPeek MS: Optimal allele-sharing statistics for genetic mapping using affected relatives. Genet Epidemiol 1999; 16: 225-249.
38. Andrade J, Andersen M, Sillén A, Graff C, Odeberg J: The use of grid computing to drive data-intensive genetic research. Eur J Hum Genet 2007; 15: 694-702.
39. Lander E, Kruglyak L: Genetic diGsection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241-247.
40. Farrer LA, Cupples LA, Haines JL et al: Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer disease meta analysis consortium. JAMA 1997; 278: 1349-1356.
41. Söderberg L, Zhukareva V, Bogdanovic N et al: Molecular identification of AMY, an Alzheimer disease amyloid-associated protein. J Neuropathol Exp Neurol 2003; 62: 1108-1117.
42. Aashimoto T, Wakabayashi T, Watanabe A et al: CLAC: a novel Alzheimer amyloid plaque component derived from a transmembrane precursor, CLAC-P/collagen type XXV. EMBO J 2002; 21: 1524-1534.
43. Dermaut B, Kumar-Singh S, Engelborghs S et al: A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques. Ann Neurol 2004; 55: 617-626.
44. Grabowski TJ, Cho HS, Vonsattel JP, Rebick GW, Greenberg SM: Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 2001; 49: 697-705.
45. Raux G, Gantier R, Thomas-Anterion C et al: Dementia with prominent frontotemporal features associated with L113P prosenilin 1 mutation. Neurology 2000; 55: 1577-1578.
46. Cabrejo L, Guyant-Marechal L, Laquerriere A et al: Phenotype associated with APP duplication in five families. Brain 2006; 129: 2966-2976.
47. Benussi L, Binetti G, Sina E et al: A novel deletion in progranulin gene is associated with FTDP-17 and CBS. Neurobiol Aging 2006 Dec 5; [Epub ahead of print].
48. Talbot K, Ansorge, O: Recent advances in the genetics of amyotrophic lateral sclerosis and frontotemporal dementia:: common pathways in neurodegenerative disease. Hum Mol Gene 2006; 15: R182-R187.
49. Ramani A, Jensen JH, Helpem JA: Quantitative MR imaging in Alzheimer disease. Radiology 2006; 241: 26-44.
50. Coon KD, Myers AJ, Craig DW et al: A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry 2007; 68: 613-618.
51. Teng J, Risch N: The relative power of family-based and case- control designs for linkage disequilibrium studies of complex human diseases. Il. Individual genotyping. Genome Res 1999; 9: 234-241.